Evidence map›Paper›PMID 37131105›Full record

SynthesisBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2023

Bactericidal activity of silver nanoparticles in drug-resistant bacteria.

C Chapa González, L I González García, L G Burciaga Jurado, A Carrillo Castillo

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Antibiofilm effect of biogenic silver nanoparticle alone and combined with polymyxin B against carbapenem-resistant Acinetobacter baumannii.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

C Chapa GonzálezGrupo de Investigación en Nanomedicina, Instituto de Ingeniería y Tecnología de la Universidad Autónoma de Ciudad Juárez, Ave. del Charro 450, Ciudad Juárez, 32310, México. christian.chapa@uacj.mx.ORCID http://orcid.org/0000-0003-1760-6116
L I González GarcíaGrupo de Investigación en Nanomedicina, Instituto de Ingeniería y Tecnología de la Universidad Autónoma de Ciudad Juárez, Ave. del Charro 450, Ciudad Juárez, 32310, México.
L G Burciaga JuradoIngeniería Biomédica, Instituto de Ingeniería y Tecnología de la Universidad Autónoma de Ciudad Juárez, Ave. del Charro 450, Ciudad Juárez, 32310, México.
A Carrillo CastilloIngeniería Biomédica, Instituto de Ingeniería y Tecnología de la Universidad Autónoma de Ciudad Juárez, Ave. del Charro 450, Ciudad Juárez, 32310, México.
Universidad Autónoma de Ciudad Juárez · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial resistance to multiple drugs is a worldwide problem that afflicts public health. Various studies have shown that silver nanoparticles are good bactericidal agents against bacteria due to the adherence and penetration of the external bacterial membrane, preventing different vital functions and subsequently bacterial cell death. A systematic review of ScienceDirect, PubMed, and EBSCOhost was conducted to synthesize the literature evidence on the association between the bactericidal property of silver nanoparticles on both resistant Gram-positive and Gram-negative bacteria. Eligible studies were original, comparative observational studies that reported results on drug-resistant bacteria. Two independent reviewers extracted the relevant information. Out of the initial 1 420, 142 studies met the inclusion criteria and were included to form the basis of the analysis. Full-text screening led to the selection of 6 articles for review. The results of this systematic review showed that silver nanoparticles act primarily as bacteriostatic agents and subsequently as bactericides, both in Gram-positive and Gram-negative drug-resistant bacteria.

Indexed as

Anti-Bacterial AgentsMetal NanoparticlesBacteriaGram-Negative BacteriaGram-Positive BacteriaMicrobial Sensitivity TestsSilverAnti-Bacterial AgentsSilverDrug-resistant bacteriaGram-negative bacteriaGram-positive bacteria

Identifiers

PMID37131105
PMCPMC10235008
OpenAlexW4367672613

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.